Introduction Coronavirus Disease 2019 is a primarily respiratory illness that can cause
thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in …

As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing
possibility that patients with COVID-19 may presen with ST-segment elevation myocardial …

The renin–aldosterone–angiotensin system (RAAS) plays an important role in the
pathogenesis of coronavirus disease 2019 (COVID-19), which is caused by the severe acute …

Little information is available on the beneficial effects of cholecalciferol treatment in
comorbid patients hospitalized for COVID-19. The aim of this study was to retrospectively …

SARS‐CoV‐2 infection has now become the world's most significant health hazard, with the
World Health Organization declaring a pandemic on March 11, 2020. COVID‐19 enters the …

The present severe acute respiratory syndrome-2 (SARS-CoV-2) mediated Coronavirus
pandemic (COVID-19) and post-COVID-19 complications affect human life drastically …

Background COVID-19 is a new form of acute respiratory failure leading to multiorgan failure
and ICU admission. Gathered evidence suggests that a 3-fold rise in D-dimer concentrations …

Background Hypercoagulability and thrombo-inflammation are the main reasons for death in
COVID-19 patients. It is unclear whether there is a difference between D-dimer levels in …

Background Many laboratory biomarkers were used for diagnosis of COVID-19 infection;
however, their accuracy to assess the severity and prognosis are still to be evaluated. This …

Objective: to screen putative associations between liver markers and proinflammatory-
related features concerning infectious morbidity and fatal outcomes in COVID-19 patients …